Similarly, elevated homocysteine levels in the liver lead to its binding with a protein called syntaxin17 (STX17), inhibiting the protein’s function in fatty acid metabolism and fat digestion, which triggers the progression of fatty liver to NASH [86,87]. The gene discussed is STX17; the disease is metabolic dysfunction-associated steatohepatitis.